VATS Versus Thoracotomy for Pulmonary Hydatid Disease

The aim of this study is to evaluate the efficacy and safety of minimally invasive surgery and compare the outcomes with patients undergoing thoracotomy in treatment of Pulmonary Hydatid Cyst.

Disease : pulmonary hydatid cyst.

Intervention:

* Group 1 : VATS approach. * Group 2 : thoracotomy approach.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pulmonary Hydatid Cyst Cestode Infections Echinococcosis Echinococcosis, Pulmonary Helminthiasis Infections Lung Diseases Lung Diseases, Parasitic Parasitic Diseases Respiratory Tract Diseases Respiratory Tract Infections

Age range

6 year–81 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hassan II University

Casablanca, 20000, Morocco

About this study

After being informed about the study and the approach, all patients giving written informed consent to determine eligibility for study entry.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

all patients underwent surgery for pulmonary hydatid cyst

Exclusion criteria

none

Treatment and study plan

VATS approach

Procedure

video-assisted thoracic surgery approach

Thoracotomy approach

Procedure

Primary outcomes

Postoperative complications

Time frame: 30 days

evaluate the complication at 30 days

Sponsors and collaborators

Lead sponsor

Hassan II University

Other

Registry information

Acronym: VATS

Important dates

Study start: 2016
Primary completion: 2019
Study completion: 2020
First posted: Jun 2, 2020
Registry last updated: Jun 2, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed